Annual Shareholders Equity
-$8.23 M
+$42.20 M+83.67%
December 31, 2023
Summary
- As of February 8, 2025, CLDI annual stockholders equity is -$8.23 million, with the most recent change of +$42.20 million (+83.67%) on December 31, 2023.
- During the last 3 years, CLDI annual shareholders equity has risen by +$14.24 million (+63.37%).
- CLDI annual shareholders equity is now at all-time high.
Performance
CLDI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$10.28 M
+$1.47 M+12.50%
September 30, 2024
Summary
- As of February 8, 2025, CLDI quarterly stockholders equity is -$10.28 million, with the most recent change of +$1.47 million (+12.50%) on September 30, 2024.
- Over the past year, CLDI quarterly shareholders equity has dropped by -$9.19 million (-839.95%).
- CLDI quarterly shareholders equity is now -839.95% below its all-time high of -$1.09 million, reached on September 30, 2023.
Performance
CLDI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CLDI Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +83.7% | -840.0% |
| 3 y3 years | +63.4% | -840.0% |
| 5 y5 years | +63.4% | -840.0% |
CLDI Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.7% | -840.0% | +83.9% |
| 5 y | 5-year | at high | +83.7% | -840.0% | +83.9% |
| alltime | all time | at high | +83.7% | -840.0% | +83.9% |
Calidi Biotherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$10.28 M(-12.5%) |
| Jun 2024 | - | -$11.75 M(-19.4%) |
| Mar 2024 | - | -$14.57 M(+77.0%) |
| Dec 2023 | -$8.23 M | -$8.23 M(+652.7%) |
| Sep 2023 | - | -$1.09 M(-98.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$63.71 M(+26.3%) |
| Dec 2022 | -$50.44 M(+59.6%) | - |
| Dec 2022 | - | -$50.44 M(+14.8%) |
| Sep 2022 | - | -$43.93 M(+39.0%) |
| Dec 2021 | -$31.61 M(+40.6%) | -$31.61 M |
| Dec 2020 | -$22.48 M | - |
FAQ
- What is Calidi Biotherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics annual shareholders equity year-on-year change?
- What is Calidi Biotherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics quarterly shareholders equity year-on-year change?
What is Calidi Biotherapeutics annual stockholders equity?
The current annual shareholders equity of CLDI is -$8.23 M
What is the all time high annual shareholders equity for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high annual stockholders equity is -$8.23 M
What is Calidi Biotherapeutics annual shareholders equity year-on-year change?
Over the past year, CLDI annual stockholders equity has changed by +$42.20 M (+83.67%)
What is Calidi Biotherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CLDI is -$10.28 M
What is the all time high quarterly shareholders equity for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high quarterly stockholders equity is -$1.09 M
What is Calidi Biotherapeutics quarterly shareholders equity year-on-year change?
Over the past year, CLDI quarterly stockholders equity has changed by -$9.19 M (-839.95%)